<DOC>
	<DOCNO>NCT00481572</DOCNO>
	<brief_summary>The purpose study determine whether : A ) continuous infusion ultra-low dose terlipressin ( 1.3 micrograms/kg/h ) able stabilize hemodynamic patient septic shock , reduce risk adverse effect relate bolus dose.B ) continuous infusion ultra-low dose terlipressin may use lieu vasopressin .</brief_summary>
	<brief_title>Continuous Infusion Terlipressin Septic Shock</brief_title>
	<detailed_description>Forty-five septic shock patient require vasopressor support maintain mean arterial pressure 65 75 mmHg despite adequate volume resuscitation enrol study . Patients randomly allocate treat either ) continuous terlipressin infusion ( 1.3 µg•kg-1 ) , b ) vasopressin ( 0.03 U•min-1 ) , c ) titrate norepinephrine ( control ; n = 15 ) . In terlipressin vasopressin group , norepinephrine additionally administer achieve mean arterial pressure ( MAP ) 65 75 mmHg , necessary . Data right heart catheterization , thermo-dye dilution catheter , gastric tonometry well data organ function , cytokine concentration , obtain baseline 12 , 24 , 36 48 hour .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Clinical diagnosis Septic shock vasopressor support maintain mean arterial pressure ( MAP ) 65 75 mmHg despite adequate volume resuscitation ( pulmonary artery occlusion pressure = 1318 mmHg central venous pressure = 812 mmHg ) Pregnancy Present cardiac dysfunction Present suspect acute mesenteric ischemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Septic Shock</keyword>
	<keyword>vasopressin</keyword>
	<keyword>terlipressin</keyword>
</DOC>